Stock Details
TMO is Thermo Fisher Scientific Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 563.89$. Average daily volumn in 3 months 1.5M. Market cap 211.43B



Stock symbol : TMO. Exchange : NYSE. Currency : USD
Lastest price : 540.11$. Total volume : 1.86M. Market state POST
Click reload if you want to check the lastest price on market!!!

Thermo Fisher Scientific Inc. (TMO)
Last Price
540.11$
Change
5.84
Volume
1.86M

Previous Close534.27
Open538.99
Day Range533.95-541.43
Bid522.66 x 800
Ask555.75 x 900
Volume1.86M
Average Volume1.5M
Market Cap211.43B
Beta0.83
52 Week Range438.72-672.34
Trailing P/E28.15
Foward P/E22.01
Dividend (Yield %)0.22%
Ex-Dividend Date2022-06-14



Financial Details


According to Thermo Fisher Scientific Inc.'s financial reports the company's revenue in 2021 were 39.21B an increase( +21.88%) over the years 2020 revenue that were of 32.22B. In 2021 the company's total earnings were 7.72B while total earnings in 2020 were 6.38B( +16.67%).


Loading ...



Organization

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical... Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Market Cap:
211.43B
Revenue:
39.21B
Total Assets:
95.12B
Total Cash:
4.48B


News about "Thermo Fisher Scientific Inc."

brokerages-expect-thermo-fisher-scientific-inc-nysetmo-will-announce-quarterly-sales-of-986-billion-image

Brokerages Expect Thermo Fisher Scientific Inc. (NYSE:TMO) Will Announce Quarterly Sales of $9.86 Billion

Source from : Defense World - 1 days ago

Brokerages expect that Thermo Fisher Scientific Inc. (NYSE:TMO โ€“ Get Rating) will post $9.86 billion in sales for the current quarter, according to Zacks. Six analysts have provided estimates for ...See details»


zacks-brokerages-expect-thermo-fisher-scientific-inc-nysetmo-to-post-493-earnings-per-share-image

Zacks: Brokerages Expect Thermo Fisher Scientific Inc. (NYSE:TMO) to Post $4.93 Earnings Per Share

Source from : Defense World - 3 days ago

Wall Street analysts expect Thermo Fisher Scientific Inc. (NYSE:TMO โ€“ Get Rating) to post earnings of $4.93 per share for the current fiscal quarter, according to Zacks. Six analysts have issued ...See details»


Thermo Fisher Scientific Inc.: Thermo Fisher's PPD Acquisition Fills Last Major Gap in Its Offering to Biopharma

Source from : YAHOO!Finance - 1 days ago

Find the latest Thermo Fisher Scientific Inc (TMO) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


svb-leerink-brokers-increase-earnings-estimates-for-thermo-fisher-scientific-inc-nysetmo-image

SVB Leerink Brokers Increase Earnings Estimates for Thermo Fisher Scientific Inc. (NYSE:TMO)

Source from : ETF Daily News - 3 days ago

Norges Bank acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $2,784,029,000. BlackRock Inc. boosted its stake in Thermo Fisher Scientific by 3.8% in the 4th ...See details»


thermo-fisher-scientific-inc-nysetmo-short-interest-update-image

Thermo Fisher Scientific Inc. (NYSE:TMO) Short Interest Update

Source from : ETF Daily News - 10 days ago

Thermo Fisher Scientific Inc. (NYSE:TMO โ€“ Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 3,390,000 shares, a growth of ...See details»


3D Cell Culture Market Key Players : Thermo Fisher Scientific Inc., Merck KGaA, Becton, Corning Incorporated, Synthecon, Inc.

Source from : Digital Journal - 22 hours ago

Theย 3D cell culture marketย revenues surpassed US$ 778 million in 2018,ย as per a new FMI study. The market is estimated to grow at 7.8% y-o-y in 2019; key ...See details»


thermo-fisher-tmo-to-advance-precision-medicine-in-qatar-image

Thermo Fisher (TMO) to Advance Precision Medicine in Qatar

Source from : YAHOO!Finance - 2 days ago

Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.See details»


signarama-completes-global-rebranding-for-thermo-fisher-scientific-image

Signarama Completes Global Rebranding for Thermo Fisher Scientific

Source from : Digital Journal - 7 days ago

Signaramaยฎ, the worldโ€™s largest sign franchise, has facilitated the recent rebranding for Thermo Fisher Scientific, following the acquisition of PPD (Pharmaceutical Product Development) โ€“ a research ...See details»


Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure

Source from : Nasdaq - 21 days ago

Thermo Fisher Scientific, Inc. TMO is rapidly boosting its inorganic growth profile through strategic acquisitions. Its strong focus on emerging markets is also encouraging. Yet, competitive ...See details»


Thermo Fisher Scientific and LabShares Partner to Support Emerging Boston Biotechs

Source from : TMCnet - 7 days ago

To support the Greater Boston biotech ecosystem, Thermo Fisher Scientific is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumables to help ...See details»


CNBC's Final Trades: Thermo Fisher Scientific, Union Pacific, A O Smith And This Semiconductor Stock

Source from : Business Insider - 22 days ago

On CNBCโ€™s โ€œHalftime Report Final Trades,โ€ Karen Firestone of Aureus Asset Management said Thermo Fisher Scientific Inc. (NYSE:TMO) โ€œmight be still up for the day. The company reported ...See details»


Thermo Fisher Scientificโ€™s Clinical Research Business Honored in CRO Leadership Awards

Source from : Daily Herald - 10 days ago

The PPD clinical research business of Thermo Fisher Scientific has been recognized for excellence in the 2022 CRO Leadership Awards. This is the 11 th consecutive year the business has been honored ...See details»


Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

Source from : Daily Herald - 3 days ago

The collaboration includes custom genotyping arrays designed to accelerate genomic research and clinical applications of predictive genomics across Arab populations Thermo Fisher Scientific, the world ...See details»


primary-hepatocytes-market-will-surpass-us-4281-mn-revenues-towards-the-end-of-2032thermo-fisher-scientific-corning-inc-and-more-image

Primary Hepatocytes Market will surpass US$ 428.1 Mn revenues towards the end of 2032|Thermo Fisher Scientific, Corning Inc and more

Source from : Medgadget - 10 days ago

Primary Hepatocytes Market 2022. The Primary Hepatocytes Market is slated to grow at a gracious rate of 6.6%, reaching US$ 428.1 Mn by the year 2022-2032. With value-oriented appr ...See details»